DNA修復薬の世界市場レポート2024

DNA修復薬の市場規模は、今後数年間で急激に成長すると予想されています。 2028年には20.2%の年間複合成長率（CAGR）で227億2,000万米ドルに成長すると予想されます。予測期間で予想される成長は、DNA修復の標的療法の進歩、精密医療の重視の高まり、高齢化の増加、DNA修復薬の開発のための資金の増強に起因すると考えられます。予測期間中に予想される注目すべき動向には、DNA修復のための創薬への人工知能の組み込み、DNA修復経路を標的とした併用療法の創出、遺伝子編集技術への焦点、DNA修復プロファイルに基づく個別化された治療計画の確立、およびDNA修復薬の臨床試験が急増しています。

DNA修復薬市場の予想される成長は、がんの有病率の増加によって促進されると予想されます。がんは、異常細胞の制御されない増殖を特徴とする疾患であり、喫煙、放射線、発がん物質、肥満、遺伝子変異などの要因の影響を受けます。がんの予防には、DNA修復機構を破壊し、がん細胞の複製を停止させ、細胞死を誘導することが含まれます。たとえば、American Cancer Society Inc.は、2023年に米国で新たにがんと診断される患者数が2020年に比べて増加し、190万人に達すると予測しています。したがって、がんの有病率の上昇は、DNA修復薬市場の成長を推進する重要な要因です。

個別化医療への需要の高まりは、DNA修復薬市場の拡大に寄与すると予想されます。個人の遺伝、環境、ライフスタイルの違いを考慮した革新的なヘルスケアアプローチである個別化医療は、DNA修復薬に依存して、患者固有の遺伝子プロファイルに基づいてカスタマイズされた治療を行います。これらの薬剤は、がん治療、バイオマーカーの特定、個別化医療の分野での副作用の最小限化に不可欠です。 The Personalized Medicine Coalitionによると、2021年に新たに承認された新規分子実体（NME）の35%が個別化医療でした。したがって、個別化医療に対する需要の高まりは、DNA修復薬市場の成長の重要な推進力となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のDNA修復薬市場、薬剤タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• オラパリブ
• ルカパリブ
• ニラパリブ
• タラゾパリブ
• その他の薬剤
• 世界のDNA修復薬市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局
• その他の流通チャネル
• 世界のDNA修復薬市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 卵巣がん
• 卵管がん
• 腹膜がん
• 乳がん
• その他の用途

第7章 地域および国の分析

• 世界のDNA修復薬市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のDNA修復薬市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• DNA修復薬市場の競合情勢
• DNA修復薬市場の企業プロファイル
  • Pfizer Inc.
  • Johnson &Johnson Private Limited
  • AbbVie Inc.
  • Bayer AG
  • Novartis AG

第31章 その他の大手および革新的な企業

• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Sanofi SA
• GlaxoSmithKline plc.
• Takeda Pharmaceutical Company Limited
• Gilead Sciences Inc.
• Amgen Inc.
• Merck KGaA
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Inc.
• Ono Pharmaceutical Co. Ltd.
• Jiangsu HengRui Medicine Co. Ltd.
• BioMarin Pharmaceutical Inc.
• Genentech Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

DNA repair drugs are pharmaceutical substances or compounds designed to accelerate or decelerate the normal processes involved in repairing damaged DNA, aiming to restore or preserve genomic integrity. These medications are targeted towards specific repair pathways or components to either prevent or treat disorders associated with DNA damage.

The primary types of DNA repair drugs include olaparib, rucaparib, niraparib, talazoparib, and others. Olaparib, for instance, is a medication prescribed for adults dealing with specific forms of prostate cancer, pancreatic cancer, breast cancer, ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, either as a standalone treatment or in combination with other medications. These drugs are made available through hospital pharmacies, retail pharmacies, and other distribution channels for the treatment of conditions such as ovarian cancer, fallopian tube cancer, peritoneal cancer, breast cancer, and more.

The DNA repair drugs research report is one of a series of new reports from The Business Research Company that provides DNA repair drugs market statistics, including the DNA repair drugs industry's global market size, regional shares, competitors with DNA repair drugs market share, detailed DNA repair drugs market segments, market trends and opportunities, and any further data you may need to thrive in the DNA repair drugs industry. This DNA repair drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dna repair drugs market size has grown exponentially in recent years. It will grow from $8.93 billion in 2023 to $10.89 billion in 2024 at a compound annual growth rate (CAGR) of 21.9%. The growth in the historical period can be ascribed to an enhanced comprehension of DNA repair mechanisms, advancements in cancer research, changes in the regulatory landscape for pharmaceuticals, a higher incidence of genetic disorders, and the expansion of personalized medicine.

The dna repair drugs market size is expected to see exponential growth in the next few years. It will grow to $22.72 billion in 2028 at a compound annual growth rate (CAGR) of 20.2%. The anticipated growth in the forecast period can be attributed to the advancement of targeted therapies for DNA repair, an increased emphasis on precision medicine, the rise in the aging population, and augmented funding for the development of DNA repair drugs. Noteworthy trends expected in the forecast period include the incorporation of artificial intelligence in drug discovery for DNA repair, the creation of combination therapies targeting DNA repair pathways, a focus on gene editing technologies, the establishment of personalized treatment regimens based on DNA repair profiles, and a surge in clinical trials for DNA repair drugs.

The anticipated growth of the DNA repair drug market is expected to be driven by the increasing prevalence of cancer. Cancer, a disease characterized by the uncontrolled proliferation of abnormal cells, is influenced by factors such as smoking, radiation, carcinogens, obesity, and genetic mutations. The prevention of cancer involves disrupting DNA repair mechanisms, leading to the cessation of cancerous cell replication and inducing cell death. For example, the American Cancer Society Inc. projects that in 2023, there will be an increase in the number of new cancer cases diagnosed in the US compared to 2020, reaching 1.9 million. Thus, the rising prevalence of cancer is a key factor propelling the growth of the DNA repair drug market.

The growing demand for personalized medicine is expected to contribute to the expansion of the DNA repair drug market. Personalized medicine, an innovative healthcare approach considering individual genetic, environmental, and lifestyle variations, relies on DNA repair drugs for tailored treatments based on patients' specific genetic profiles. These drugs are integral in cancer treatment, biomarker identification, and minimizing adverse effects in the realm of personalized medicine. According to The Personalized Medicine Coalition, personalized medicines accounted for 35% of newly approved new molecular entities (NMEs) in 2021. Hence, the increasing demand for personalized medicine is a significant driver for the growth of the DNA repair drug market.

DNA repair drug market is witnessing a prominent trend of product innovation. Leading companies in the DNA repair drugs sector are actively engaged in developing groundbreaking products to fortify their market presence. A notable example is AstraZeneca PLC, a UK-based biopharmaceutical company, which secured approval in June 2023 for Lynparza plus abiraterone in the United States. This approval is specifically for treating BRCA-mutated metastatic castration-resistant prostate cancer. Lynparza (olaparib), the first-of-its-kind PARP inhibitor, represents a breakthrough as the initial targeted drug capable of blocking the DNA damage response (DDR) in cells or tumors without homologous recombination repair (HRR).

Major players in the DNA repair drug market are directing their efforts toward the development of innovative solutions, such as oral poly ADP-ribose polymerase (PARP) inhibitors. These medications, administered orally, are designed to target the PARP enzyme's activity. Pfizer Inc., a prominent US-based pharmaceutical company, exemplifies this trend with the FDA approval announcement in June 2023 for 'TALZENNA' (talazoparib). TALZENNA, the first and only PARP inhibitor approved for use alongside the established standard of care, XTANDI, is intended for adult patients diagnosed with metastatic castration-resistant prostate cancer (mCRPC) exhibiting mutations in homologous recombination repair (HRR) genes. By inhibiting PARP enzyme activity and capturing PARP at the DNA damage site, TALZENNA hinders cancer cell growth and induces cell death.

In November 2022, Alexion Pharmaceuticals Inc., a US-based biopharmaceutical company specializing in rare disorder therapies, acquired LogicBio Therapeutics Inc. for an undisclosed sum. This acquisition positions Alexion to expedite its foray into genomic therapeutics, leveraging LogicBio's distinctive technology, seasoned rare disease R&D team, and expertise in pre-clinical development. LogicBio Therapeutics Inc. is a clinical-stage genetic medicine company with a focus on gene delivery and gene editing platforms to address rare diseases.

Major companies operating in the dna repair drugs market report are Pfizer Inc., Johnson & Johnson Private Limited, AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Jiangsu HengRui Medicine Co. Ltd., BioMarin Pharmaceutical Inc., Genentech Inc., Clovis Oncology Inc., Karyopharm Therapeutics Inc., Repare Therapeutics Inc., Intellia Therapeutics Inc., C4 Therapeutics Inc., Precision BioSciences, Artios Pharma Limited, FoRx Therapeutics AG, Onxeo SA, CRISPR Therapeutics AG

North America was the largest region in the DNA repair drugs market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the dna repair drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dna repair drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA repair drugs market consists of sales of veliparib, methyl methane sulfonate, mitomycin C, and cisplatin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Repair Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna repair drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna repair drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna repair drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Drug Type: Olaparib; Rucaparib; Niraparib; Talazoparib; Other Drugs
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
• 3) By Application: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer; Other Applications
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Private Limited; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA Repair Drugs Market Characteristics

3. DNA Repair Drugs Market Trends And Strategies

4. DNA Repair Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global DNA Repair Drugs Market Size and Growth

• 5.1. Global DNA Repair Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global DNA Repair Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global DNA Repair Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. DNA Repair Drugs Market Segmentation

• 6.1. Global DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Olaparib
• Rucaparib
• Niraparib
• Talazoparib
• Other Drugs
• 6.2. Global DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels
• 6.3. Global DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer
• Breast Cancer
• Other Applications

7. DNA Repair Drugs Market Regional And Country Analysis

• 7.1. Global DNA Repair Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global DNA Repair Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific DNA Repair Drugs Market

• 8.1. Asia-Pacific DNA Repair Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China DNA Repair Drugs Market

• 9.1. China DNA Repair Drugs Market Overview
• 9.2. China DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India DNA Repair Drugs Market

• 10.1. India DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan DNA Repair Drugs Market

• 11.1. Japan DNA Repair Drugs Market Overview
• 11.2. Japan DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia DNA Repair Drugs Market

• 12.1. Australia DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia DNA Repair Drugs Market

• 13.1. Indonesia DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea DNA Repair Drugs Market

• 14.1. South Korea DNA Repair Drugs Market Overview
• 14.2. South Korea DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe DNA Repair Drugs Market

• 15.1. Western Europe DNA Repair Drugs Market Overview
• 15.2. Western Europe DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK DNA Repair Drugs Market

• 16.1. UK DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany DNA Repair Drugs Market

• 17.1. Germany DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France DNA Repair Drugs Market

• 18.1. France DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy DNA Repair Drugs Market

• 19.1. Italy DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain DNA Repair Drugs Market

• 20.1. Spain DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe DNA Repair Drugs Market

• 21.1. Eastern Europe DNA Repair Drugs Market Overview
• 21.2. Eastern Europe DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia DNA Repair Drugs Market

• 22.1. Russia DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America DNA Repair Drugs Market

• 23.1. North America DNA Repair Drugs Market Overview
• 23.2. North America DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA DNA Repair Drugs Market

• 24.1. USA DNA Repair Drugs Market Overview
• 24.2. USA DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada DNA Repair Drugs Market

• 25.1. Canada DNA Repair Drugs Market Overview
• 25.2. Canada DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America DNA Repair Drugs Market

• 26.1. South America DNA Repair Drugs Market Overview
• 26.2. South America DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil DNA Repair Drugs Market

• 27.1. Brazil DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East DNA Repair Drugs Market

• 28.1. Middle East DNA Repair Drugs Market Overview
• 28.2. Middle East DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa DNA Repair Drugs Market

• 29.1. Africa DNA Repair Drugs Market Overview
• 29.2. Africa DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. DNA Repair Drugs Market Competitive Landscape And Company Profiles

• 30.1. DNA Repair Drugs Market Competitive Landscape
• 30.2. DNA Repair Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson Private Limited
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. DNA Repair Drugs Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca PLC
• 31.3. Sanofi S.A.
• 31.4. GlaxoSmithKline plc.
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Gilead Sciences Inc.
• 31.7. Amgen Inc.
• 31.8. Merck KGaA
• 31.9. Regeneron Pharmaceuticals Inc.
• 31.10. Biogen Inc.
• 31.11. Vertex Pharmaceuticals Inc.
• 31.12. Ono Pharmaceutical Co. Ltd.
• 31.13. Jiangsu HengRui Medicine Co. Ltd.
• 31.14. BioMarin Pharmaceutical Inc.
• 31.15. Genentech Inc.

32. Global DNA Repair Drugs Market Competitive Benchmarking

33. Global DNA Repair Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The DNA Repair Drugs Market

35. DNA Repair Drugs Market Future Outlook and Potential Analysis

• 35.1 DNA Repair Drugs Market In 2028 - Countries Offering Most New Opportunities
• 35.2 DNA Repair Drugs Market In 2028 - Segments Offering Most New Opportunities
• 35.3 DNA Repair Drugs Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer